Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Dominant mutations in superoxide dismutase cause amyotrophic lateral sclerosis (ALS), a progressive paralytic disease characterized by loss of motor neurons. With the use of mice carrying a deletable mutant gene, expression within motor neurons was shown to be a primary determinant of disease onset and of an early phase of disease progression. Diminishing the mutant levels in microglia had little effect on the early disease phase but sharply slowed later disease progression. Onset and progression thus represent distinct disease phases defined by mutant action within different cell types to generate non–cell-autonomous killing of motor neurons; these findings validate therapies, including cell replacement, targeted to the non-neuronal cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“accumulation of mutant SOD1 in microglia may further amplify their proinflammatory and neurotoxic activity (149, 150).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [150]
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Microglia as a source and target of cytokines
Hanisch, U. (2002) · Glia · doi:10.1002/glia.10161 · Cited by 1,645
Wong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,445
Self-citationBruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341
Self-citationUNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS
Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144244 · Cited by 1,185
Self-citationWild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W., Siwek, D., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,100
Self-citation
Research works printed but not linked: 2
- T. Kawamata, H. Akiyama, T. Yamada, P. L. McGeer, Am. J. Pathol.140, 691 (1992).
- A. Mazzone, G. Ricevuti, Haematologica80, 161 (1995).
Cited by
Items 601–700 of 1,001
Genetic manipulation of microglia during brain development and disease
Wieghofer, P., & Prinz, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.019 · Cited by 61
Winter, A. N., Ross, E. K., Wilkins, H. M., Stankiewicz, T. R., Wallace, T., Miller, K., & Linseman, D. A. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1297023 · Cited by 58
Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis
Olesen, M. N., Wuolikainen, A., Nilsson, A. C., Wirenfeldt, M., Forsberg, K., Madsen, J. S., Lillevang, S. T., Brandslund, I., Andersen, P. M., & Asgari, N. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000697 · Cited by 57
Yang, C., Qiao, T., Yu, J. H., Wang, H., Guo, Y., Salameh, J. S., Metterville, J., Parsi, S., Yusuf, I. O., Brown, R. H., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0255710 · Cited by 68
Zhang, R., Hadlock, K. G., Do, H., Yu, S., Honrada, R., Champion, S., Forshew, D., Madison, C., Katz, J., Miller, R. G., et al. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.012 · Cited by 57
Vaknin, I., Kunis, G., Miller, O., Butovsky, O., Bukshpan, S., Beers, D. R., Henkel, J. S., Yoles, E., Appel, S. H., & Schwartz, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026921 · Cited by 57
TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study
Weehaeghe, D. V., Schoor, E. V., Vocht, J. D., Koole, M. J. B., Attili, B. N. N. R., Celen, S., Declercq, L., Thal, D. R., Damme, P. V., Bormans, G. M., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.231985 · Cited by 60
Lee, C. Y. D., Cantle, J. P., & Yang, X. W. (2013) · The FEBS Journal · doi:10.1111/febs.12418 · Cited by 56
Trias, E., Díaz-Amarilla, P., Olivera-Bravo, S., Isasi, E., Drechsel, D. A., Lopez, N., Bradford, C. S., Ireton, K. E., Beckman, J. S., & Barbeito, L. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00274 · Cited by 56
Ng, S. K., Higashimori, H., Tolman, M., & Yang, Y. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.03.004 · Cited by 59
Hossaini, M., Cano, S. C., van Dis, V., Haasdijk, E. D., Hoogenraad, C. C., Holstege, J. C., & Jaarsma, D. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31822581ac · Cited by 67
Pastor, D., Viso-León, M. C., Jones, J., Jaramillo-Merchán, J., Toledo‐Aral, J. J., Moraleda, J. M., & Martínez, S. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9295-x · Cited by 58
Zhu, Y.-B., & Sheng, Z.-H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.237818 · Cited by 56
Lunn, J. S., Hefferan, M. P., Maršala, M., & Feldman, E. L. (2009) · Growth Factors · doi:10.1080/08977190902814855 · Cited by 60
Oussini, H. E., Bayer, H., Scekic‐Zahirovic, J., Vercruysse, P., Sinniger, J., Dirrig‐Grosch, S., Dieterle, S., Echaniz‐Laguna, A., Larmet, Y., Müller, K., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1534-4 · Cited by 65
Impaired activation of ALS monocytes by exosomes
Zondler, L., Feiler, M. S., Freischmidt, A., Ruf, W. P., Ludolph, A. C., Danzer, K. M., & Weishaupt, J. H. (2017) · Immunology & Cell Biology · doi:10.1038/icb.2016.89 · Cited by 56
Role of RNA Binding Proteins with prion-like domains in muscle and neuromuscular diseases
Picchiarelli, G., & Dupuis, L. (2020) · Cell Stress · doi:10.15698/cst2020.04.217 · Cited by 59
11 C‐PK11195 PET–based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosis
Tondo, G., Iaccarino, L., Cerami, C., Vanoli, G. E., Presotto, L., Masiello, V., Coliva, A., Salvi, F., Bartolomei, I., Mosca, L., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51112 · Cited by 56
“SOD1 mutations are considered as a potent trigger of microglia cells, and deleterious effects of microglial activation have been reported in SOD1-ALS animal models.(34) In vivo PET imaging represents a useful tool to quantify and localize microglial activity and possibly to assess response to novel therapeutic interve…”
BackgroundIslam, F., Islam, M. R., Meem, A. F. K., Nafady, M. H., Islam, M. R., Akter, A., Mitra, S., Alhumaydhi, F. A., Emran, T. B., Khusro, A., et al. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.136020 · Cited by 56
RetractedAstrocyte signaling and neurodegeneration: New insights into CNS disorders
Brambilla, L., Martorana, F., & Rossi, D. (2013) · Prion · doi:10.4161/pri.22512 · Cited by 55
Khanna, A., & Arora, B. (2009) · International journal of business science & applied management. · doi:10.69864/ijbsam.4-3.43 · Cited by 90
High-Resolution 7T MR Imaging of the Motor Cortex in Amyotrophic Lateral Sclerosis
Cosottini, M., Donatelli, G., Costagli, M., Ienco, E. C., Frosini, D., Pesaresi, I., Biagi, L., Siciliano, G., & Tosetti, M. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4562 · Cited by 59
Vaz, A. R., Pinto, S., Ezequiel, C., Cunha, C., Carvalho, L. A., Moreira, R., & Brites, D. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00109 · Cited by 55
Mir-17∼92 Confers Motor Neuron Subtype Differential Resistance to ALS-Associated Degeneration
Tung, Y.-T., Peng, K.-C., Chen, Y.-C., Yen, Y.-P., Chang, M., Thams, S., & Chen, J.-A. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.04.016 · Cited by 53
Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis
Patel, B. P., & Hamadeh, M. J. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.06.002 · Cited by 64
Thams, S., Lowry, E. R., Larraufie, M.-H., Spiller, K. J., Li, H., Williams, D. J., Hoang, P., Jiang, E., Williams, L. A., Sandoe, J., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2018.10.010 · Cited by 51
Gao, C., Shi, Q., Pan, X., Chen, J., Zhang, Y., Lang, J., Wen, S., Liu, X., Cheng, T., & Lei, K. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113892 · Cited by 66
Limone, F., Mordes, D. A., Couto, A., Joseph, B. J., Mitchell, J. M., Therrien, M., Ghosh, S. D., Meyer, D., Zhang, Y., Goldman, M., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00640-0 · Cited by 53
Lui, A., & Byl, N. N. (2009) · Neurology Report · doi:10.1097/npt.0b013e31819912d0 · Cited by 68
Tanaka, K., Kanno, T., Yanagisawa, Y., Yasutake, K., Hadano, S., Yoshii, F., & Ikeda, J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.001 · Cited by 58
Disease-Modifying Pathways in Neurodegeneration
Finkbeiner, S., Maria Cuervo, A., Morimoto, R. I., & Muchowski, P. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3829-06.2006 · Cited by 54
Jaiswal, M. K. (2014) · Molecular and Cellular Therapies · doi:10.1186/2052-8426-2-26 · Cited by 65
Quantitative patterns of motor cortex proteinopathy across ALS genotypes
Nolan, M., Scott, C., Pallebage‐Gamarallage, M. M., Lunn, D., Carpenter, K., McDonough, E., Meyer, D. E., Kaanumalle, S., Santamaría-Pang, A., Turner, M. R., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00961-2 · Cited by 58
Yamashita, H., Kawamata, J., Okawa, K., Kanki, R., Nakamizo, T., Hatayama, T., Yamanaka, K., Takahashi, R., & Shimohama, S. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04534.x · Cited by 54
Self-citationModeling Brain Disorders Using Induced Pluripotent Stem Cells
Vadodaria, K. C., Jones, J. R., Linker, S. B., & Gage, F. H. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a035659 · Cited by 54
Glia-specific autophagy dysfunction in ALS
Strohm, L., & Behrends, C. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.024 · Cited by 58
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact
Marchi, F. D., Munitić, I., Amedei, A., Berry, J. D., Feldman, E. L., Aronica, E., Nardo, G., Weehaeghe, D. V., Niccolai, E., Prtenjača, N., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.027 · Cited by 54
Gowing, G., Lalancette-Hébert, M., Audet, J.-N., Dequen, F., & Julien, J.-P. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.021 · Cited by 53
Dupuis, L., & Echaniz‐Laguna, A. (2010) · Current Drug Targets · doi:10.2174/1389450111007011250 · Cited by 58
Stem Cell-Derived Motor Neurons: Applications and Challenges in Amyotrophic Lateral Sclerosis
Thonhoff, J. R., Ojeda, L. D., & Wu, P. (2009) · Current Stem Cell Research & Therapy · doi:10.2174/157488809789057392 · Cited by 56
Qiu, L., Qiao, T., Beers, M., Tan, W., Wang, H., Yang, B., & Xu, Z. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-1 · Cited by 53
Patin, F., Corcia, P., Vourc’h, P., Nadal‐Desbarats, L., Baranek, T., Goossens, J., Marouillat, S., Dessein, A., Descat, A., Hounoum, B. M., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0078-x · Cited by 54
Drosophila Glia: Models for Human Neurodevelopmental and Neurodegenerative Disorders
Kim, T., Song, B., & Lee, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144859 · Cited by 64
Prion-Like Characteristics of Polyglutamine-Containing Proteins
Pearce, M. M. P., & Kopito, R. R. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024257 · Cited by 55
Motor neuron–immune interactions: the vicious circle of ALS
Barbeito, A. G., Mesci, P., & Boillée, S. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0429-0 · Cited by 63
Dibaj, P., Zschüntzsch, J., Steffens, H., Scheffel, J., Göricke, B., Weishaupt, J. H., Meur, K. L., Kirchhoff, F., Hanisch, U., Schomburg, E. D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043963 · Cited by 53
Physical Activity and Neuroprotection in Amyotrophic Lateral Sclerosis
McCrate, M., & Kaspar, B. K. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8030-5 · Cited by 62
Pasetto, L., Pozzi, S., Castelnovo, M., Basso, M., Estevez, A. G., Fumagalli, S., De Simoni, M. G., Castellaneta, V., Bigini, P., Restelli, E., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2462-16.2016 · Cited by 52
Barbeito, A. G., Martinez-Palma, L., Vargas, M. R., Pehar, M., Mañay, N., Beckman, J. S., Barbeito, L., & Cassina, P. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.007 · Cited by 52
The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis
Cox, L. M., Calcagno, N., Gauthier, C., Madore, C., Butovsky, O., & Weiner, H. L. (2022) · Microbiome · doi:10.1186/s40168-022-01232-z · Cited by 53
“Modulating levels of mutant SOD1 in motor neurons affects disease onset and the earlier stages of disease [18, 26] whereas selectively silencing mutant SOD1 in microglia delays motor neuron degeneration and extends survival [13].”
BackgroundPoppe, L., Rué, L., Robberecht, W., & Van Den Bosch, L. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.07.001 · Cited by 51
Ueno, M., & Yamashita, T. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.02.004 · Cited by 62
Advances in stem cell research for Amyotrophic Lateral Sclerosis
Papadeas, S. T., & Maragakis, N. J. (2009) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2009.09.003 · Cited by 53
Emerging drugs for amyotrophic lateral sclerosis
Habib, A. A., & Mitsumoto, H. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.604312 · Cited by 54
Progression in primary lateral sclerosis: A prospective analysis
Floeter, M. K., & Mills, R. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960903171136 · Cited by 54
Hayashi, M., Arima, H., Ozaki, N., Morishita, Y., Hiroi, M., Ozaki, N., Nagasaki, H., Kinoshita, N., Ueda, M., Shiota, A., et al. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00034.2009 · Cited by 49
Current Therapy of Drugs in Amyotrophic Lateral Sclerosis
Lu, H., Le, W. D., Xie, Y.-Y., & Wang, X.-P. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160120152423 · Cited by 60
Rabinovich-Nikitin, I., Ezra, A., Barbiro, B., Rabinovich‐Toidman, P., & Solomon, B. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0587-6 · Cited by 53
Yacoubian, T. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802810-0.00001-5 · Cited by 77
Kim, J. H., Lukowicz, A., Qu, W., Johnson, A., & Cvetanović, M. (2018) · Glia · doi:10.1002/glia.23451 · Cited by 50
Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice
Bonfanti, E., Bonifacino, T., Raffaele, S., Milanese, M., Morgante, E., Bonanno, G., Abbracchio, M. P., & Fumagalli, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072395 · Cited by 51
Inflammation-dependent oxidative stress metabolites as a hallmark of amyotrophic lateral sclerosis
Xiong, L., McCoy, M. G., Komuro, H., West, X. Z., Yakubenko, V. P., Gao, D., Dudiki, T., Milo, A., Chen, J. M., Podrez, E. A., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.11.031 · Cited by 55
You, J., Youssef, M., Santos, J. R., Lee, J., & Park, J. (2023) · Biology · doi:10.3390/biology12101307 · Cited by 68
Amyotrophic lateral sclerosis caused by TARDBP mutations: from genetics to TDP-43 proteinopathy
Balendra, R., Sreedharan, J., Hallegger, M., Luisier, R., Lashuel, H. A., Gregory, J. M., & Patani, R. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00109-7 · Cited by 66
Morioka, N., Tanabe, H., Inoue, A., Dohi, T., & Nakata, Y. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.03.004 · Cited by 51
Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival
Staats, K. A., & Bosch, L. V. D. (2009) · Journal of Biological Physics · doi:10.1007/s10867-009-9141-4 · Cited by 59
Inhibition of Microglia Activation as a Phenotypic Assay in Early Drug Discovery
Figuera-Losada, M., Rojas, C., & Slusher, B. S. (2014) · SLAS Discovery · doi:10.1177/1087057113499406 · Cited by 49
Ohnishi, S., Ito, H., Suzuki, Y., Adachi, Y., Wate, R., Zhang, J., Nakano, S., Kusaka, H., & Ikehara, S. (2009) · Brain Research · doi:10.1016/j.brainres.2009.08.012 · Cited by 51
Neuroprotective roles of the P2Y2 receptor
Weisman, G. A., Ajit, D., Garrad, R. C., Peterson, T. S., Woods, L. T., Thebeau, C. N., Camden, J. M., & Erb, L. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9307-6 · Cited by 63
Nanomaterials as Microglia Modulators in the Treatment of Central Nervous System Disorders
Battaglini, M., Marino, A., Montorsi, M., Carmignani, A., Ceccarelli, M. C., & Ciofani, G. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202304180 · Cited by 58
An α2-Na/K ATPase/α-adducin complex in astrocytes triggers non–cell autonomous neurodegeneration
Gallardo, G., Barowski, J., Ravits, J., Siddique, T., Lingrel, J. B., Robertson, J., Steen, H., & Bonni, A. (2014) · Nature Neuroscience · doi:10.1038/nn.3853 · Cited by 49
Modulators of Nucleoside Metabolism in the Therapy of Brain Diseases
Boison, D. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795347609 · Cited by 56
Milanese, M., Giribaldi, F., Melone, M., Bonifacino, T., Musante, I., Carminati, E., Rossi, P. I. A., Vergani, L., Voci, A., Conti, F., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.006 · Cited by 59
New insights into SMA pathogenesis: immune dysfunction and neuroinflammation
Deguise, M., & Kothary, R. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.423 · Cited by 58
Iannitti, T., Scarrott, J. M., Likhite, S., Coldicott, I. R. P., Lewis, K. E., Heath, P. R., Higginbottom, A., Myszczynska, M. A., Milo, M., Hautbergue, G. M., et al. (2018) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2018.04.015 · Cited by 49
Revisiting the role of the innate immune complement system in ALS
Parker, S. E., Hanton, A. M., Stefanou, S. N., Noakes, P. G., Woodruff, T. M., & Lee, J. D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.03.003 · Cited by 55
Martin, L. J., & Wong, M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.592851 · Cited by 53
An MD2-perturbing peptide has therapeutic effects in rodent and rhesus monkey models of stroke
Fang, Z., Wu, D., Deng, J., Yang, Q., Zhang, X., Chen, J., Wang, S., Hu, S., Hou, W., Ning, S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb6716 · Cited by 48
Moran, L. B., Croisier, E., Duke, D. C., Kalaitzakis, M. E., Roncaroli, F., Deprez, M., Dexter, D. T., Pearce, R. K. B., & Graeber, M. B. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0181-6 · Cited by 55
Cao, M. C., Cawston, E. E., Chen, G. L., Brooks, C., Douwes, J. E., McLean, D., Graham, E. S., Dragunow, M., & Scotter, E. L. (2022) · BMC Neurology · doi:10.1186/s12883-022-02730-1 · Cited by 53
Human iPSC co-culture model to investigate the interaction between microglia and motor neurons
Vahsen, B. F., Gray, E., Candalija, A., Cramb, K. M. L., Scaber, J., Dafinca, R., Katsikoudi, A., Xu, Y., Farrimond, L. E., Wade‐Martins, R., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-16896-8 · Cited by 62
Feng, R., Zhu, Q., Wang, A., Wang, H., Wang, J., Chen, P., Zhang, R., Liang, D., Teng, J., Ma, M., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03781-6 · Cited by 53
Bergemalm, D., Forsberg, K., Srivastava, V., Graffmo, K. S., Andersen, P. M., Brännström, T., Wingsle, G., & Marklund, S. L. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06753.x · Cited by 54
Altered astrocytic expression of TDP-43 does not influence motor neuron survival
Haidet-Phillips, A. M., Gross, S. K., Williams, T. L., Tuteja, A., Sherman, A., Ko, M., Jeong, Y. H., Wong, P. C., & Maragakis, N. J. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.10.004 · Cited by 57
Nanou, A., Higginbottom, A., Valori, C. F., Wyles, M., Ning, K., Shaw, P., & Azzouz, M. (2013) · Molecular Therapy · doi:10.1038/mt.2013.115 · Cited by 48
Crosstalk between astrocytes and motor neurons: What is the message?
Bosch, L. V. D., & Robberecht, W. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.01.008 · Cited by 58
Tokuda, E., Okawa, E., Watanabe, S., & Ono, S.-I. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt517 · Cited by 50
Karumbayaram, S., Kelly, T. K., Paucar, A. A., Roe, A. J. T., Umbach, J. A., Charles, A., Goldman, S. A., Kornblum, H. I., & Wiedau-Pazos, M. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.002113 · Cited by 48
Fujisawa, T., Takahashi, M., Tsukamoto, Y., Yamaguchi, N., Nakoji, M., Endo, M., Kodaira, H., Hayashi, Y., Nishitoh, H., Naguro, I., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv467 · Cited by 47
Lenzi, J., Pagani, F., Santis, R. D., Limatola, C., Bozzoni, I., Angelantonio, S. D., & Rosa, A. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.06.003 · Cited by 52
Garbuzova-Davis, S. N., Kurien, C., Thomson, A., Falco, D., Ahmad, S., Staffetti, J. F., Steiner, G. A., Abraham, S., James, G. V., Mahendrasah, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00993-0 · Cited by 50
Zheng, W., Li, Q., Zhao, C., Da, Y., Zhang, H., & Chen, Z. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00239 · Cited by 56
Zhang, X., Chen, S., Lu, K., Wang, F., Deng, J., Xu, Z., Wang, X., Zhou, Q., Le, W., & Zhao, Y. (2019) · Aging and Disease · doi:10.14336/ad.2019.0228 · Cited by 49
Enhanced neuronal Met signalling levels in ALS mice delay disease onset
Genestine, M., Caricati, E., Fico, A., Richelme, S., Hassani, H., Sunyach, C., Lamballe, F., Panzica, G., Pettmann, B., Helmbacher, F., et al. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.11 · Cited by 50
Degeneration of serotonin neurons triggers spasticity in amyotrophic lateral sclerosis
El Oussini, H., Scekic‐Zahirovic, J., Vercruysse, P., Marques, C., Dirrig‐Grosch, S., Dieterlé, S., Picchiarelli, G., Sinniger, J., Rouaux, C., & Dupuis, L. (2017) · Annals of Neurology · doi:10.1002/ana.25030 · Cited by 47
“To determine the role of serotonergic neurons in ALS, we used floxed SOD1(G37R) mice, which express the ALS-linked G37R mutation in the human SOD1 gene that can be excised through Cre-mediated recombination.(17) These mice have been widely used to determine the respective roles of motor neurons, microglia, astrocytes,…”
MethodInfluentialOliván, S., Martínez‐Beamonte, R., Calvo, A. C., Surra, J. C., Manzano, R., Arnal, C., Osta, R., & Osada, J. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.04.005 · Cited by 56
Relationship between neuropathology and disease progression in the SOD1G93A ALS mouse
Yang, W. W., Sidman, R. L., Taksir, T. V., Treleaven, C. M., Fidler, J. A., Cheng, S. H., Dodge, J. C., & Shihabuddin, L. S. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.11.019 · Cited by 54
Calpastatin inhibits motor neuron death and increases survival of hSOD1G93A mice
Rao, M. V., Campbell, J., Palaniappan, A. R., Kumar, A. R., & Nixon, R. A. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13536 · Cited by 53
The Role of Cyclo(His-Pro) in Neurodegeneration
Grottelli, S., Ferrari, I., Pietrini, G., Peirce, M. J., Minelli, A., & Bellezza, I. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081332 · Cited by 52
Evidence for a protective role of the CX3CL1/CX3CR1 axis in a model of amyotrophic lateral sclerosis
Liu, C., Hong, K., Chen, H., Niu, Y., Duan, W., Liu, Y., Ji, Y., Deng, B., Li, Y., Li, Z., et al. (2019) · Biological Chemistry · doi:10.1515/hsz-2018-0204 · Cited by 47
Metadata
- Authors
- Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W.
- Affiliations
- Ludwig Institute for Cancer Research and Departments of Medicine and Neuroscience, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
- University of California San Diego (US)
- ORCID
- Venue
- Science
- Published
- 2006-06-02
- Volume
- 312
- Issue
- 5778
- Pages
- 1389-1392
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2033158384
- Cited by
- 1,623
- References
- 28
- Citations by year
- 2026: 42 · 2025: 40 · 2024: 52 · 2023: 59 · 2022: 69 · 2021: 60 · 2020: 95 · 2019: 82 · 2018: 74 · 2017: 84 · 2016: 82 · 2015: 81 · 2014: 109 · 2013: 107 · 2012: 115
- FWCI
- 66.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS 27036, R37NS027036)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- amyotrophic lateral sclerosis, motor neurons, microglia, disease onset, disease progression, cell replacement therapy, mouse model
- MeSH terms
- Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Animals, Female, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Motor Neurons, Mutation, Superoxide Dismutase, Microglia, Disease Progression, Integrases, CD11b Antigen, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.